Low prevalence of SPINK1 gene mutations in adult patients with chronic idiopathic pancreatitis
暂无分享,去创建一个
[1] M. Manns,et al. Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. , 2000, Gastroenterology.
[2] M. Manns,et al. Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis , 2000, American Journal of Gastroenterology.
[3] Olfert Landt,et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis , 2000, Nature Genetics.
[4] Fricker,et al. Mouse model of spinal muscular atrophy. , 2000, Drug discovery today.
[5] A. Bird,et al. Confirmation of the assignment of the Sanjad-Sakati (congenital hypoparathyroidism) syndrome (OMIM 241410) locus to chromosome lq42-43 , 2000, Journal of medical genetics.
[6] Y L Wang,et al. Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence-based carrier testing for spinal muscular atrophy. , 1999, American journal of medical genetics.
[7] T. Wienker,et al. Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutations in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling. , 1999, American journal of human genetics.
[8] A. Munnich,et al. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis , 1999, Journal of medical genetics.
[9] D. Parsons,et al. Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. , 1998, American journal of human genetics.
[10] M. Knowles,et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. , 1998, The New England journal of medicine.
[11] M. Schwarz,et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. , 1998, The New England journal of medicine.
[12] J. Melki,et al. The role of the SMN gene in proximal spinal muscular atrophy. , 1998, Human molecular genetics.
[13] C. Lewis,et al. Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy , 1998, European Journal of Human Genetics.
[14] K. Davies,et al. Maternal mosaicism for a second mutational event in a type I spinal muscular atrophy family. , 1998, American journal of human genetics.
[15] Daniel L. Koller,et al. Heterogeneity in hereditary pancreatitis. , 1998, American journal of medical genetics.
[16] B. Wirth,et al. De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. , 1997, American journal of human genetics.
[17] J. Mendell,et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. , 1997, American journal of human genetics.
[18] M. Gorry,et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene , 1996, Nature Genetics.
[19] K. Devriendt,et al. Unusual molecular findings in autosomal recessive spinal muscular atrophy. , 1996, Journal of medical genetics.
[20] E. Velasco,et al. Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. , 1996, Human molecular genetics.
[21] A. Munnich,et al. A frame–shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients , 1995, Nature Genetics.
[22] B. Dallapiccola,et al. Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. , 1995, Biochemical and biophysical research communications.
[23] B. Wirth,et al. Allelic association and deletions in autosomal recessive proximal spinal muscular atrophy: association of marker genotype with disease severity and candidate cDNAs. , 1995, Human molecular genetics.
[24] J. Osinga,et al. PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy , 1995, The Lancet.
[25] T. Crawford,et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy , 1995, Cell.
[26] J. Weissenbach,et al. Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.
[27] D. Le Paslier,et al. De novo and inherited deletions of the 5q13 region in spinal muscular atrophies. , 1994, Science.
[28] J. Pearn,et al. Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. , 1978, Journal of medical genetics.
[29] J. Pearn. The Gene Frequency of Acute Werdnig-Hoffmann Disease (SMA Type 1). A Total Population Survey in North-East England , 1973, Journal of medical genetics.
[30] M. Schwartz,et al. Quantification, by solid-phase minisequencing, of the telomeric and centromeric copies of the survival motor neuron gene in families with spinal muscular atrophy. , 1997, Human molecular genetics.
[31] D. Bartelt,et al. Human pancreatic secretory trypsin inhibitor. , 1976, Methods in enzymology.